Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease:: A comparison with untreated patients and normal age-matched controls

被引:0
|
作者
Ramig, LO
Sapir, S
Fox, C
Countryman, S
机构
[1] Denver Ctr Performing Arts, Wilbur James Gould Voice Ctr, Denver, CO 80204 USA
[2] Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO USA
[3] Univ Arizona, Natl Ctr Neurogen Commun Disorders, Dept Speech & Hearing Sci, Tucson, AZ USA
关键词
LSVT (R); Parkinson's disease; speech therapy; vocal loudness; dysarthria;
D O I
10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study assessed the impact of the Lee Silverman Voice Treatment (LSVT(R)) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre- to post-treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT(R) and in non-disordered individuals. ape-matched to the patients. All subjects produced the same voice and speech tasks-sustaining vowel phonation. reading the "Rainbow Passage," producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment. just after treatment, and 6 months following treatment. The individuals treated with LSVT(R) increased voice SPL from baseline to post-treatment by an average of 8 dB and from baseline to 6 months follow-up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow-up. Differences in SPL between the treated and untreated patients at post-treatment and follow-up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT(R).
引用
收藏
页码:79 / 83
页数:5
相关论文
共 20 条
  • [1] Speech loudness and quality 12 months after intensive voice treatment (LSVT®) for Parkinson's disease:: A comparison with an alternative speech treatment
    Sapir, S
    Ramig, LO
    Hoyt, P
    Countryman, S
    O'Brien, C
    Hoehn, M
    FOLIA PHONIATRICA ET LOGOPAEDICA, 2002, 54 (06) : 296 - 303
  • [2] Intensive voice treatment (LSVT®) for patients with Parkinson's disease:: a 2 year follow up
    Ramig, LO
    Sapir, S
    Countryman, S
    Pawlas, AA
    O'Brien, C
    Hoehn, M
    Thompson, LL
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (04): : 493 - 498
  • [3] Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus
    Spielman, Jennifer
    Mahler, Leslie
    Halpern, Angela
    Gilley, Phllip
    Klepitskaya, Olga
    Ramig, Lorraine
    JOURNAL OF COMMUNICATION DISORDERS, 2011, 44 (06) : 688 - 700
  • [4] A PET study of functional reorganization of premotor regions in Parkinson's disease following intensive speech and voice treatment (LSVT)
    Liotti, M
    Vogel, D
    New, P
    Ramig, L
    Mayberg, HS
    Cook, CI
    Fox, PT
    NEUROLOGY, 1999, 52 (06) : A348 - A349
  • [5] Voice quality changes following phonatory-respiratory effort treatment (LSVT®) versus respiratory effort treatment for individuals with Parkinson disease
    Baumgartner, CA
    Sapir, S
    Ramig, LO
    JOURNAL OF VOICE, 2001, 15 (01) : 105 - 114
  • [6] Studying emergence of behavioral changes during one month of intensive voice treatment (LSVT) in a person with Parkinson's disease
    Spielman, J.
    Halpern, A.
    Ramig, L.
    Fox, C.
    MOVEMENT DISORDERS, 2007, 22 : S181 - S182
  • [7] Comparison of the SCOPA-COG, MMSE and Mattis Dementia Rating Scale in Parkinson's disease patients and age-matched controls
    Rabey, J. M.
    Prokhorov, T.
    Dobronevsky, E.
    Pollak, L.
    Khaigrekht, M.
    Klein, C.
    MOVEMENT DISORDERS, 2006, 21 : S584 - S584
  • [8] Comparison of the SCOPA-COG, MMSE and mattis dementia rating scale in Parkinson's disease patients (PDpts) and age-matched Controls
    Rabey, Jose
    Prokhorov, Tatiana
    Dobronevsky, Eugenia
    Miniovitch, Ala
    Pollak, Lea
    Khaigrackht, Michael
    Klein, Colin
    NEUROLOGY, 2007, 68 (12) : A34 - A34
  • [9] Functional Aspects of Gait in Essential Tremor: A Comparison with Age-Matched Parkinson's Disease Cases, Dystonia Cases, and Controls
    Louis, Elan D.
    Rao, Ashwini K.
    TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2015, 5
  • [10] Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
    Unger, Marcus M.
    Spiegel, Joerg
    Dillmann, Klaus-Ulrich
    Grundmann, David
    Philippeit, Hannah
    Buermann, Jan
    Fassbender, Klaus
    Schwiertz, Andreas
    Schaefer, Karl-Herbert
    PARKINSONISM & RELATED DISORDERS, 2016, 32 : 66 - 72